摘要 |
This method is in part related to recently licensed methods of using quinolone antibiotics, in particular a gemifloxacine compound against certain pathogenic bacteria, such as bacteria chosen from the group consisting of Acinobacter spp., Enterobacter spp., Proteus mirabilis, Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa. |